Zobrazeno 1 - 10
of 1 560
pro vyhledávání: ''
Autor:
Philippe Armand, Robert J. Soiffer, Joseph H. Antin, Areej El-Jawahri, Yi Bin Chen, Brett Glotzbecker, Vincent T. Ho, Corey Cutler, Sarah Nikiforow, Zachariah DeFilipp, Natasha Kekre, Rizwan Romee, Haesook T. Kim, Mahasweta Gooptu, Julia Hofer, John Koreth, Edwin P. Alyea, Prashant Nageshwar
Publikováno v:
Bone Marrow Transplantation. 56:1006-1012
The α4s7 integrin is upregulated on naive and memory T cell subsets in patients who subsequently develop gastrointestinal (GI) acute GVHD. Natalizumab (Tysabri®, Biogen Inc.) acts against the α4 subunit that mediates homing of lymphocytes to the G
Autor:
Manuela Badoglio, Laure Ricard, M. C. B. Oliveira, Juliana Bernardes Elias Dias, Daniela A. Moraes, Mohamad Mohty, Dominique Farge, Zora Marjanovic, Charlotte Laurent, Arsène Mekinian, Renate Arnold, Joerg Henes, Olivier Fain, Michael Soussan, John A. Snowden, Tobias Alexander, Remy Dulery
Publikováno v:
Bone Marrow Transplantation. 55:2109-2113
Autologous hematopoietic stem cell transplantation (AHSCT) has emerged as a promising treatment option in severely affected and refractory patients with autoimmune diseases. This is a retrospective survey of patients reported to the EBMT registry bet
Autor:
Herve Finel, Marrow Transplantation, Gérard Socié, Eva Domingo-Domenech, Joerg Thomas Bittenbring, Fina Climent, Peter Dreger, Frank Kroschinsky, M Stelljes, Damir Nemet, Anna Sureda, E. Vandenbergue, Stephen P. Robinson, Ariane Boumendil, Silvia Montoto
Publikováno v:
Bone Marrow Transplantation. 55:633-640
Information regarding the curative role of allogeneic stem cell transplantation (allo-HCT) in systemic anaplastic large cell lymphoma (sALCL) is scarce. We analyzed the results of allo-HCT in patients with relapsed/refractory sALCL with special empha
Autor:
Liisa Volin, Wieslaw Wiktor-Jedrzejczak, Donald Bunjes, Leopold Sellner, Per Ljungman, M Rovira, Gerald Wulf, Maija Itälä-Remes, Yener Koc, Michael Potter, Jennifer Hoek, Tobias Gedde-Dahl, Robert Foa, Arnon Nagler, Amit Patel, Jürgen Finke, Jan J. Cornelissen, Patrice Chevallier, A. van Biezen, Nicolaus Kröger, Pascal Turlure, M. J. de Groot, Johannes Schetelig, Péter Reményi, Diderik Jan Eikema, Peter Dreger, Sonja Martin, E. Deconinck, Arne Brecht, Joanna Drozd-Sokołowska, Matthew Collin, Simona Iacobelli
Publikováno v:
Bone marrow transplantation, 54(9), 1391-1398. Nature Publishing Group
Bone Marrow Transplantation, 54(9), 1391-1398. Nature Publishing Group
Bone Marrow Transplantation, 54(9), 1391-1398. Nature Publishing Group
Preliminary data suggest that allogeneic stem cell transplantation (allo-SCT) may be effective in T-prolymphocytic leukemia (T-PLL). The purpose of the present observational study was to assess the outcome of allo-SCT in patients aged 65 years or you
Autor:
Annalisa Ruggeri, Arnon Nagler
Publikováno v:
Bone Marrow Transplantation. 54:713-718
Allogeneic stem cell transplantations (alloSCT) from haploidentical (>2 HLA mismatch) donors (HaploSCT) are constantly increasing in Europe. From 2005 to 2015 numbers of HaploSCT increased by close to 300%. In parallel, there is a major shift from T
Autor:
Patrizia Chiusolo, Sabrina Giammarco, Carmen Di Grazia, Maria Teresa Van Lint, Federica Sorà, Andrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, Alida Dominietto, Luca Laurenti, Francesca Gualandi
Publikováno v:
Bone Marrow Transplantation. 54:708-712
This is an update on acute and chronic graft-versus-host disease (GvHD) in 425 patients with hematologic malignancies, undergoing an unmanipulated haploidentical (HAPLO) graft from related donors, with a modified post-transplant cyclophosphamide (PT-
Autor:
Dani Hakimeh, Peter Lang, Angelika Eggert, Selim Corbacioglu, Patrick Hundsdörfer, Lena Oevermann, Pietro Sodani, Friederike Kogel, Johannes H. Schulte
Publikováno v:
Bone Marrow Transplantation. 54:743-748
We review current approaches in HLA-haploidentical hematopoietic stem cell transplantation (haplo-HSCT) for pediatric patients with hemoglobinopathies with a focus on recent developments using TCRα/β+/CD19+ depleted grafts in patients with β-thala
Autor:
David H. Vesole, David S. Siegel, Andrew Pecora, Alan P Skarbnik, Shijia Zhang, Joshua Richter, Scott D. Rowley, Noa Biran, Michele L. Donato
Publikováno v:
Bone Marrow Transplantation. 54:1881-1891
A regimen of escalating doses of thalidomide, in combination with bortezomib and high-dose melphalan (mel/vel/thal), was evaluated as a conditioning regimen for autologous stem cell transplantation (ASCT) in multiple myeloma (MM) patients with a prio
Autor:
Iracema Esteves, José Salvador Rodrigues de Oliveira, Juliana Folloni Fernandes, Fabio R. Kerbauy, Fabio P.S. Santos, Marcos de Lima, Nelson Hamerschlak, Adriana Seber, Borje S. Andersson
Publikováno v:
Bone Marrow Transplantation. 54:1799-1804
Busulfan is used in myeloablative schemes for hematopoietic stem cell transplantation (HSCT), with monitoring of dosage through the area under the curve (AUC) of the drug plasma concentration (µMol min). In this study, we compared the complete pharm
Autor:
Stefania Bramanti, Didier Blaise, Faezeh Legrand, Valerio Maisano, Reda Bouabdallah, Luca Castagna, Pierre-Jean Weiller, Raynier Devillier, Djamel Mokart, Samia Harbi, Angela Granata, Jacopo Mariotti, Catherine Faucher, Chiara De Philippis, Barbara Sarina, Christian Chabannon, Norbert Vey, Sabine Furst, Boris Calmels, Claude Lemarie
Publikováno v:
Bone Marrow Transplantation. 54:1730-1737
While bone marrow (BM) grafts were initially used for T-replete HLA-haploidentical related donors transplantation (Haplo-SCT) with post-transplantation cyclophosphamide (PT-Cy), the use of peripheral blood stem cell (PBSC) remains debated. We thus co